Skip to main content
. Author manuscript; available in PMC: 2013 Feb 7.
Published in final edited form as: Curr Biol. 2004 Aug 10;14(15):1319–1329. doi: 10.1016/j.cub.2004.07.052

Table 1.

Gain-of-Function Cho Organ Phenotypes

Driver Gene/Construct % Partial/Complete
Transformationa
% Total
Defectsb
Number/Type of
Hemisegmentsc
Elav EP-robo2 44 58.4 457 abd
Atonal EP-robo2 30.5 40 151 abd
Elav UAS-robo2d 21 41 56 abd
Elav UAS-roboY→F 6.1 8.7 196 abd
Elav UAS-roboicc2cc3 0 0 119 abd
Elav UAS-robo3d 0 0 364 abd
Elav EP-robo2 (25°C) 32 58 262 abd
Elav EP-robo2; +/slit(25°C) 17.2 32.6 319 abd
Elav EP-robo2, roboZ2130 36.4 49.4 324 abd
VM EP-robo2 17 41 247 abd
0 1.5 68 tho
VM UAS-robo3d 0 0 70 abd
VM UAS-robo2-Δcytod 5.4 14.2 742 abd
9 10.8 212 tho
VM UAS-roboY→F 0.2 0.7 406 abd
0 0.9 114 tho

All experiments were performed at 29°C unless specified otherwise.

Abbreviations: abd, abdominal segments; tho, thoracic segments.

a

Similar to triple or double asterisked examples shown in Figure 2J.

b

Similar to any of the defects shown in Figure 2J.

c

Thoracic segments were unaffected unless specified otherwise.

d

robo2 and robo3 transgenes are myc-tagged.